At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 24 enrolled
Drug / intervention
aminolevulinic acid hydrochloride +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Photodynamic Therapy (PDT) With Levulan and Blue Light for the Treatment of Actinic Cheilitis
In Brief
A Phase 4 clinical trial evaluating aminolevulinic acid hydrochloride and Photodynamic therapy with blue light for Actinic Cheilitis. Completed, enrolled 24 participants across 1 site.
Detailed Summary
To evaluate the safety and efficacy of PDT with blue light and topical Levulan in the treatment of actinic cheilitis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsActinic Cheilitis
CountriesUnited States
CollaboratorsDUSA Pharmaceuticals, Inc.
Timeline
Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartApr 2015
First PostedApr 2015
Primary CompletionJul 2017
TodayJul 2026
First PostedApr 7, 2015
Enrollment StartApr 1, 2015
Primary CompletionJul 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 11.2 years ago
Interventions
aminolevulinic acid hydrochloridedrug
Photodynamic therapy with blue lightprocedure